Bioreactivity Markers in Total Hip Replacments
Bioreactivity Markers in Total Hip Replacments
批准号:
6719633
负责人:
Nadim James Hallab
金额:
$7.25万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-22 至 2005-02-28
关键词:
arthroplastybiomarkerbiomaterial compatibilityblood testscollagendiagnosis design /evaluationdisease /disorder proneness /riskgene expressionhip prosthesishuman subjectimmunogeneticsimmunoregulationinflammationionsleukocyteslongitudinal human studymedical complicationmedical implant sciencemetalsorthopedicsparticlepathologic bone resorptionpathologic processpatient oriented researchstatistics /biometryurinalysis
中文摘要
描述(由申请人提供):该项目涉及
全髋关节降解产物免疫反应现象
关节成形术(THA)部件导致骨丢失和植入物失效。这
建议侧重于离子和颗粒生物材料诱导的细胞
THA患者淋巴细胞和单核细胞/巨噬细胞的反应。它
临床上继续观察到,一些全关节患者
关节成形术可以耐受颗粒负荷和金属蛋白复合物
长期形成(>8年),
植入物周围反应,而其他患者似乎等同
颗粒和离子负荷在2-7
年,导致种植体周围骨吸收。免疫系统的细胞
主要负责这些事件的调解。被巨噬细胞吞噬的颗粒,
金属-蛋白质复合物与淋巴细胞相互作用可导致产生
以自分泌和旁分泌的方式起作用,
增加骨吸收或减少骨形成。在我们
初步研究表明,1)分解代谢骨变化的标志物
THA后升高; 2)来自选定THA患者的淋巴细胞,
对某些金属盐的高反应性;和3)来自患有
THA处于致敏状态,产生大量细胞因子,
与单核细胞相比,类花生酸对颗粒碎片激发的响应
与正常人隔离。我们假设免疫系统的血清标志物
THA患者的反应性和胶原蛋白水平升高,
骨质溶解和无菌性松动,以及离子(金属-蛋白质复合物)和
颗粒植入物碎片在不同的组织中产生不同水平的反应性,
个体,部分通过免疫细胞的可变激活,
系统我们建议通过血清和尿液的相关性来检验这些假设
炎症和胶原蛋白分解代谢的标志物
在一个充分表征的THA患者队列中,
在单个时间点(A1-A4组)观察骨质溶解,然后使用这些
在发生骨质溶解之前,确定了指示骨质溶解发生的标志物
临床症状和/或影像学变化,
前瞻性随访患者队列的血清和尿液(组
131-134)。此外,植入物诱导的可变免疫应答
降解产物(即淋巴细胞对金属离子的反应,
单核细胞/巨噬细胞对颗粒碎片的反应)将与
骨质溶解的发展
英文摘要
DESCRIPTION (provided by applicant): This project is concerned with the
phenomenon of immunologic reactivity to degradation products of total hip
arthroplasty (THA) components leading to bone loss and implant failure. This
proposal focuses on ionic and particulate biomaterial-induced cellular
responses of lymphocytes and monocytes/macrophages in patients with THA. It
continues to be observed clinically that some patients with total joint
arthroplasties can tolerate particulate burden and metal-protein complex
formation for long periods of time (>8 years) with relatively little
peri-implant reactivity, whereas other patients with seemingly equivalent
particulate and ionic burdens demonstrate pronounced reactivity within 2-7
years, resulting in peri-implant bone resorption. Cells of the immune system
primarily mediate these events. Particles phagocytosed by macrophages and
metal-protein complexes interacting with lymphocytes can lead to the production
of factors which act in both an autocrine and paracrine fashion and contribute
to either increased bone resorption or reduced bone formation. In our
preliminary work, it has been shown that 1) markers of catabolic bone changes
are elevated after THA; 2) lymphocytes from selected patients with THA are
hyper-responsive to certain metal salts; and 3) monocytes from patients with
THA are in a sensitized state and produce larger amounts of cytokines and
eicosanoids in response to challenge with particulate debris than monocytes
isolated from normal individuals. We hypothesize that serum markers of immune
reactivity and collagen catabolism are elevated in THA patients prone to
osteolysis and aseptic loosening and that ionic (metal-protein complexes) and
particulate implant debris produce diverse levels of reactivity in different
individuals, in part, through variable activation of cells of the immune
system. We propose to test these hypotheses by correlating serum and urine
markers of inflammation and Collagen catabolism with the development of
osteolysis in a wellcharacterized cohort of THA patients with and without
osteolysis at a single time point (Groups AI-A4), and then to use these
identified markers to indicate the onset of osteolysis prior to the development
of clinical symptoms and/or radiographic changes within the annually collected
serum and urine of a prospectively followed cohort of patients (Groups
131-134). Additionally, variable immunologic responses induced by implant
degradation products (i.e. lymphocyte response to metal ions and
monocyte/macrophage response to particulate debris) will be correlated with the
development of osteolysis
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Determination of excessive immune reactivity to real time implant debris generate
-
批准号:9455400
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2017
-
负责人:Nadim James Hallab
-
依托单位:
Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced Osteolysis
-
批准号:8546267
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2012
-
负责人:Nadim James Hallab
-
依托单位:
Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced Osteolysis
-
批准号:8368926
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2012
-
负责人:Nadim James Hallab
-
依托单位:
Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced Osteolysis
-
批准号:8666518
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2012
-
负责人:Nadim James Hallab
-
依托单位:
Bioreactivity Markers in Total Hip Replacments
-
批准号:6620955
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2002
-
负责人:Nadim James Hallab
-
依托单位:
Bioreactivity Markers in Total Hip Replacments
-
批准号:6424574
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2002
-
负责人:Nadim James Hallab
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
-
批准号:81101308
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李海霞
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
精神分裂症记忆障碍的脑网络组学研究
-
批准号:91132301
-
项目类别:重大研究计划
-
资助金额:350.0万元
-
批准年份:2011
-
负责人:蒋田仔
-
依托单位:
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
-
批准号:81072363
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:郑红
-
依托单位:
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
-
批准号:81060151
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2010
-
负责人:赵学凌
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: